Literature DB >> 7685411

Cottontail rabbit papillomavirus L1 protein-based vaccines: protection is achieved only with a full-length, nondenatured product.

Y L Lin1, L A Borenstein, R Ahmed, F O Wettstein.   

Abstract

Papillomas induced by the cottontail rabbit papillomavirus (CRPV) progress at a high frequency to carcinomas. In this regard, CRPV and its tumors can serve as an animal model for highly oncogenic human papillomaviruses. We have previously shown that immunization with major structural protein L1 elicits neutralizing antibodies and protects rabbits from papilloma development (Y.-L. Lin, L.A. Borenstein, R. Selvakumar, R. Ahmed, and F.O. Wettstein, Virology 187:612-619, 1992). In this study, we demonstrated that vaccination with the TrpE-L1 fusion protein not only protected rabbits from papilloma development but also prevented latent infection. This was indicated by the failure to amplify CRPV sequences by polymerase chain reaction in biopsies from infection sites of immunized animals. Furthermore, we showed that TrpE-L1 immunization protected rabbits from papilloma formation induced by virus but not from that induced by viral DNA. To explore the possibility of developing vaccines based on L1 subfragments, we mapped the linear L1 epitopes recognized by TrpE-L1-immunized rabbits and by virus-infected rabbits resistant to superinfection. Sera from papilloma-bearing rabbits reacted with one major epitope located at the carboxy-terminal end of L1, between amino acids (aa) 480 and 505. A second epitope, and in some animals a third one, was located in the amino-terminal region, between aa 78 and 101, as well as between aa 37 and 62. Sera from TrpE-L1-immunized animals recognized only one major epitope, located between aa 6 and 37. Immunization of rabbits with L1 subfragment fusion proteins led to seroconversion, but no neutralizing antibodies were produced and the animals were not protected against papilloma formation. The data indicate that a successful papillomavirus vaccine must be based on immunization with full-length native L1 and that further simplification to smaller peptides containing major linear epitopes is not feasible.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685411      PMCID: PMC237784     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  STUDIES ON THE MECHANISM RESPONSIBLE FOR THE SPONTANEOUS REGRESSION OF THE SHOPE RABBIT PAPILLOMA.

Authors:  J W KREIDER
Journal:  Cancer Res       Date:  1963-10       Impact factor: 12.701

2.  Antitumor immunity in the Shope papilloma-carcinoma complex of rabbits. I. Papilloma regression induced by homologous and autologous tissue vaccines.

Authors:  C A EVANS; L R GORMAN; Y ITO; R S WEISER
Journal:  J Natl Cancer Inst       Date:  1962-08       Impact factor: 13.506

3.  A vaccination procedure which increases the frequency of regressions of Shope papillomas of rabbits.

Authors:  C A EVANS; L R GORMAN; Y ITO; R S WEISER
Journal:  Nature       Date:  1962-01-20       Impact factor: 49.962

4.  Use of a rapid, efficient inoculation method to induce papillomas by cottontail rabbit papillomavirus DNA shows that the E7 gene is required.

Authors:  J L Brandsma; Z H Yang; S W Barthold; E A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

5.  Antitumor immunity in the Shope papilloma-carcinoma complex of rabbits. 3. Response to reinfection with viral nucleic acid.

Authors:  C A Evans; Y Ito
Journal:  J Natl Cancer Inst       Date:  1966-06       Impact factor: 13.506

6.  Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11.

Authors:  N D Christensen; J W Kreider; N M Cladel; S D Patrick; P A Welsh
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

7.  The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes.

Authors:  N D Christensen; J W Kreider; N C Kan; S L DiAngelo
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

8.  Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli.

Authors:  K R Spindler; D S Rosser; A J Berk
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

9.  Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts.

Authors:  D Defeo-Jones; G A Vuocolo; K M Haskell; M G Hanobik; D M Kiefer; E M McAvoy; M Ivey-Hoyle; J L Brandsma; A Oliff; R E Jones
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  Progression from papilloma to carcinoma is accompanied by changes in antibody response to papillomavirus proteins.

Authors:  Y L Lin; L A Borenstein; R Selvakumar; R Ahmed; F O Wettstein
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

View more
  20 in total

1.  Recombinant Listeria monocytogenes vaccination eliminates papillomavirus-induced tumors and prevents papilloma formation from viral DNA.

Authors:  E R Jensen; R Selvakumar; H Shen; R Ahmed; F O Wettstein; J F Miller
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Plant-produced cottontail rabbit papillomavirus L1 protein protects against tumor challenge: a proof-of-concept study.

Authors:  T Kohl; I I Hitzeroth; D Stewart; A Varsani; V A Govan; N D Christensen; A-L Williamson; E P Rybicki
Journal:  Clin Vaccine Immunol       Date:  2006-08

3.  Regression of papillomas induced by cottontail rabbit papillomavirus is associated with infiltration of CD8+ cells and persistence of viral DNA after regression.

Authors:  R Selvakumar; A Schmitt; T Iftner; R Ahmed; F O Wettstein
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

Review 4.  Roots and perspectives of contemporary papillomavirus research.

Authors:  H zur Hausen
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 5.  How will HPV vaccines affect cervical cancer?

Authors:  Richard Roden; T-C Wu
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

6.  Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease.

Authors:  Jon D Reuter; Beatriz E Vivas-Gonzalez; Daniel Gomez; Jean H Wilson; Janet L Brandsma; Heather L Greenstone; John K Rose; Anjeanette Roberts
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies.

Authors:  R C Rose; W I White; M Li; J A Suzich; C Lane; R L Garcea
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  Protective immunity to rabbit oral and cutaneous papillomaviruses by immunization with short peptides of L2, the minor capsid protein.

Authors:  Monica E Embers; Lynn R Budgeon; Martin Pickel; Neil D Christensen
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Wounding prior to challenge substantially improves infectivity of cottontail rabbit papillomavirus and allows for standardization of infection.

Authors:  Nancy M Cladel; Jiafen Hu; Karla Balogh; Andres Mejia; Neil D Christensen
Journal:  J Virol Methods       Date:  2007-12-03       Impact factor: 2.014

10.  Cervarix: a vaccine for the prevention of HPV 16, 18-associated cervical cancer.

Authors:  Archana Monie; Chien-Fu Hung; Richard Roden; T-C Wu
Journal:  Biologics       Date:  2008-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.